Cargando…
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
Prostate cancer (PC) is a hormone-sensitive tumor. Androgen deprivation therapy (ADT) is the cornerstone of systemic therapy for patients with intermediate or high-risk localized, recurrent, and metastatic prostate cancer. Although generally well tolerated, ADT can lead to short- and long-term adver...
Autores principales: | Turco, Fabio, Di Prima, Lavinia, Pisano, Chiara, Poletto, Stefano, De Filippis, Marco, Crespi, Veronica, Farinea, Giovanni, Cani, Massimiliano, Calabrese, Mariangela, Saporita, Isabella, Di Stefano, Rosario Francesco, Tucci, Marcello, Buttigliero, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869701/ https://www.ncbi.nlm.nih.gov/pubmed/36698681 http://dx.doi.org/10.2147/RRU.S350793 |
Ejemplares similares
-
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
por: Audisio, Marco, et al.
Publicado: (2022) -
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022) -
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
por: Ungaro, Antonio, et al.
Publicado: (2022) -
Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
por: Fiorica, Francesco, et al.
Publicado: (2022) -
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)